<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03713073</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-DB-18-0303</org_study_id>
    <nct_id>NCT03713073</nct_id>
  </id_info>
  <brief_title>Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free Gingival Graft Donor Site</brief_title>
  <official_title>Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free Gingival Graft Donor Site</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare an allogenic amnion chorion membrane to a collagen
      dressing in palatal wound healing after harvesting free gingival graft (FGG).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 3, 2016</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study is a &quot;split-mouth design&quot; , in which two treatments (test and control) are randomly assigned to either the right or left halves of the dentition/palate.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>baseline</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>4 days</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>10 days</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>2 weeks</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>3 weeks</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>4 weeks</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>6 weeks</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size of wound area</measure>
    <time_frame>8 weeks</time_frame>
    <description>The wound area will be assessed by means of a clinical picture. The picture will be taken with an angulation perpendicular to the wound. A periodontal probe will be placed by the wound as a reference scale. Wound area is defined as the area without epithelization. The wound area on the picture will be measured by ImageJ.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>baseline</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>4 days</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>10 days</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>2 weeks</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>3 weeks</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>4 weeks</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>6 weeks</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of epithelialization of wound</measure>
    <time_frame>8 weeks</time_frame>
    <description>Epithelialization is measured by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface. Less bubbles indicate greater epithelialization, and epithelialization will be ranked as total, partial or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>baseline</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>4 days</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>10 days</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>2 weeks</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>3 weeks</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>4 weeks</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>6 weeks</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative difference in color of wound site compared to adjacent gingiva</measure>
    <time_frame>8 weeks</time_frame>
    <description>The color of wound site will be compared to the adjacent gingiva by using a 4-point scale: 1. Obvious difference; 2. Noticeable difference; 3. Disguisable difference; or 4. No noticeable difference in comparison with adjacent gingiva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>baseline</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>4 days</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>10 days</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>2 weeks</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>3 weeks</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>4 weeks</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>6 weeks</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with haemostasis of wound area</measure>
    <time_frame>8 weeks</time_frame>
    <description>Haemostasis is achieved when no bleeding of the wound site is actively seen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>baseline</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>4 days</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>10 days</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by a Visual Analogue Scale (VAS)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pain will be assessed by a Visual Analogue Scale (VAS). Scores range form 0 to 10. 0 indicates no pain, 1 indicates minimal pain, and 10 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>baseline</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>4 days</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>10 days</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>3 weeks</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of the wound area as assessed by a 3-point verbal descriptor scale (VDS)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sensitivity will be assessed with a periodontal probe using a rubbing movement and pin-pressure nociception. Patients will be asked to rate their sensitivity based on a 3-point verbal descriptor scale (VDS): none, mild/moderate, or severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>baseline</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>4 days</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>10 days</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>2 weeks</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>3 weeks</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>4 weeks</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>6 weeks</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of wound</measure>
    <time_frame>8 weeks</time_frame>
    <description>The wound area will analyzed with an intraoral scanner, and three-dimensional images will be reconstructed to determine the volume of the wound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician's feedback on the wound dressing material as assessed by a questionnaire</measure>
    <time_frame>at the time of placement of the wound dressing material</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cellular composition of inflammatory infiltrates as assessed by light microscopy of haematoxylin and eosin (H&amp;E)-stained biopsy sections</measure>
    <time_frame>baseline</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cellular composition of inflammatory infiltrates as assessed by light microscopy of haematoxylin and eosin (H&amp;E)-stained biopsy sections</measure>
    <time_frame>10 days</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of new collagen as assessed by light microscopy of Masson's trichrome-stained biopsy sections</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of new collagen as assessed by light microscopy of Masson's trichrome-stained biopsy sections</measure>
    <time_frame>10 days</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope, and Nikon NIS Element AR Imagine Software will be used to calculate the percentage of the new collagen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the epithelium as assessed by light microscopy of haematoxylin and eosin (H&amp;E)-stained biopsy sections</measure>
    <time_frame>baseline</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope, and Nikon NIS Element AR Imagine Software will be used to calculate the thickness of the epithelium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the epithelium as assessed by light microscopy of haematoxylin and eosin (H&amp;E)-stained biopsy sections</measure>
    <time_frame>10 days</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope, and Nikon NIS Element AR Imagine Software will be used to calculate the thickness of the epithelium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiogenesis as assessed by light microscopy of biopsy sections immunohistochemically stained to detect factor VIII (von Willebrandt factor)</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiogenesis as assessed by light microscopy of biopsy sections immunohistochemically stained to detect factor VIII (von Willebrandt factor)</measure>
    <time_frame>10 days</time_frame>
    <description>Gingival specimen biopsies (4mm in diameter, 1.5mm in thickness) will be harvested. The histological sections will be evaluated using a Nikon light microscope, and the area of angiogenesis will be quantified using Nikon NIS Element AR Imagine Software.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Palatal Wound</condition>
  <arm_group>
    <arm_group_label>Allogenic amnion chorion membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Allogenic amnion chorion membrane (ACM) is a minimally manipulated allograft amnion chorion tissue for use as a wound covering in dental surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Collagen dressing is used to cover wounds in dental surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Allogenic amnion chorion membrane</intervention_name>
    <description>Allogenic amnion chorion membrane (ACM) is a minimally manipulated allograft amnion chorion tissue for use as a wound covering in dental surgery.</description>
    <arm_group_label>Allogenic amnion chorion membrane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Collagen dressing</intervention_name>
    <description>Collagen dressing is used to cover wounds in dental surgery.</description>
    <arm_group_label>Collagen dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients attending the Clinic for Graduate Periodontics at The University of Texas
             health Science Center at Houston School of Denstistry who are in need of a Free
             Gingival Graft procedure to augment keratinized gingiva, augment ridge, or cover
             recession defects.

          -  systemically healthy or with controlled common systemic conditions, such as
             hypertension, that will not affect wound healing.

        Exclusion Criteria:

          -  size of the FGG that the patient needs bigger than the size of FGGs that have to be
             harvested in this study (two 8mm (width) x 10mm (length) x ≈1.5mm (thickness) FGG).

          -  current heavy smokers(&gt;10 cigarettes/day) (patients who stop smoking more than one
             year are eligible)

          -  have diabetes or other systemic diseases that may comprise healing

          -  take antibiotics and/or analgesics within one week before the procedure and have loss
             of sensation on the palate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Teh Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun-Teh Lee, DDS, MS, DMSC</last_name>
    <phone>713-486-4384</phone>
    <email>Chun-Teh.Lee@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun-Teh Lee, DDS, MS, DMSC</last_name>
      <phone>713-486-4384</phone>
      <email>Chun-Teh.Lee@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Seonghong Min, DDS, MS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Chun-Teh Lee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

